Show simple item record

dc.contributor.authorBourgeois, Florence
dc.contributor.authorDoshi, Peter
dc.contributor.authorHong, Kyungwan
dc.contributor.authorJefferson, Tom
dc.contributor.authorJones, Mark
dc.contributor.authorLee, Haeyoung
dc.contributor.authorRowhani-Farid, Anisa
dc.contributor.authorShamseer, Larissa
dc.contributor.authorSpence, O'Mareen
dc.date.accessioned2020-11-18T14:14:47Z
dc.date.available2020-11-18T14:14:47Z
dc.date.issued2020-11-04
dc.identifier.urihttp://hdl.handle.net/10713/14101
dc.description.urihttps://doi.org/10.1128/mSphere.00770-20en_US
dc.language.isoenen_US
dc.publisherAmerican Society for Microbiologyen_US
dc.relation.ispartofmSphereen_US
dc.subjectdrug regulationen_US
dc.subjectdrug safetyen_US
dc.subjectevidence-based medicineen_US
dc.subjecttransparencyen_US
dc.titleIncompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trialen_US
dc.typeOtheren_US
dc.identifier.doi10.1128/mSphere.00770-20
dc.identifier.pmid33148819
dc.source.volume5
dc.source.issue6
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record